Niki BioSolutions, Inc. (NIKI) Capital Leases (2018 - 2022)
Niki BioSolutions' (NIKI) quarterly Capital Leases came in at $22106.0 in Q2 2021, down 69.71% YoY from $72986.0 in Q2 2020, and down 53.87% on a QoQ basis from $47923.0 in Q4 2020.
Niki BioSolutions, Inc. (NIKI) Capital Leases (2018 - 2022) Analysis & Trends
Niki BioSolutions (NIKI) has 4 years of Capital Leases data on file, last reported at $22106.0 in Q2 2021.
- Quarterly Capital Leases fell 69.71% year-over-year to $22106.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $22106.0 (down 69.71% YoY) and the FY2020 annual result came in at $47923.0, down 50.76% from the prior year.
- Capital Leases eased to $22106.0 in Q2 2021, from $47923.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $143873.0 in Q4 2018 to a low of $22106.0 in Q2 2021.
- A 4-year average of $84191.3 and a median of $85152.5 in 2019 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2019 — Capital Leases plunged 32.36% — and 2021, when it plunged 69.71%.
- Tracing NIKI's Capital Leases over 4 years: stood at $143873.0 in 2018, then sank by 32.36% to $97319.0 in 2019, then slumped by 50.76% to $47923.0 in 2020, then plunged by 53.87% to $22106.0 in 2021.
- The last three Capital Leases figures came in at $22106.0 (Q2 2021), $47923.0 (Q4 2020), and $72986.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -49,358.00 |
| Jun 30, 2022 | -26.92 Bn |
| Jun 30, 2021 | 22,106.00 |
| Dec 31, 2020 | 47,923.00 |
| Jun 30, 2020 | 72,986.00 |
| Dec 31, 2019 | 97,319.00 |
| Jun 30, 2019 | 120,941.00 |
| Dec 31, 2018 | 143,873.00 |